Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets
- 9 June 2007
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 50 (8) , 1752-1762
Abstract
Gastric inhibitory polypeptide (GIP) receptor antagonism with (Pro3)GIP improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure/function in ob/ob mice. This study examined the ability of (Pro3)GIP to counter the development of obesity, insulin resistance and diabetes in mice fed high-fat and cafeteria diets.Keywords
This publication has 41 references indexed in Scilit:
- Rising Incidence of Type 2 Diabetes in Children in the U.K.Diabetes Care, 2007
- Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in AdipocytesJournal of Biological Chemistry, 2007
- The role of gut hormones in glucose homeostasisJournal of Clinical Investigation, 2007
- Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditureJournal of Clinical Investigation, 2007
- Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric SurgeryDiabetes, 2006
- Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin actionBiochemical and Biophysical Research Communications, 2005
- Physiology of GIP - A Lesson from GIP Receptor Knockout MiceHormone and Metabolic Research, 2004
- Lack of the metabotropic glutamate receptor subtype 7 selectively impairs short-term working memory but not long-term memoryBehavioural Brain Research, 2004
- GIP or not GIP? That is the questionTrends in Pharmacological Sciences, 2003
- The effect of energy source and feeding level on the hormones of the entero-insular axis and plasma glucose in the growing pigBritish Journal of Nutrition, 1991